Xu, T.; Tuerxun, P.; Liu, N.; Ji, C.; Zhao, K.; Qian, Y.; Abudushataer, A.; Li, Y.; Jiang, X.; Xiong, Z.;
et al. Deferred Versus Upfront Cytoreductive Nephrectomy in MetaStatic Renal Cell Carcinoma: Comparative Survival Analysis in the Immunotherapy Era. Cancers 2025, 17, 3136.
https://doi.org/10.3390/cancers17193136
AMA Style
Xu T, Tuerxun P, Liu N, Ji C, Zhao K, Qian Y, Abudushataer A, Li Y, Jiang X, Xiong Z,
et al. Deferred Versus Upfront Cytoreductive Nephrectomy in MetaStatic Renal Cell Carcinoma: Comparative Survival Analysis in the Immunotherapy Era. Cancers. 2025; 17(19):3136.
https://doi.org/10.3390/cancers17193136
Chicago/Turabian Style
Xu, Tao, Paerhati Tuerxun, Ning Liu, Chencheng Ji, Kunlun Zhao, Yiguan Qian, Abudukelimu Abudushataer, Yang Li, Xiaotian Jiang, Zhongli Xiong,
and et al. 2025. "Deferred Versus Upfront Cytoreductive Nephrectomy in MetaStatic Renal Cell Carcinoma: Comparative Survival Analysis in the Immunotherapy Era" Cancers 17, no. 19: 3136.
https://doi.org/10.3390/cancers17193136
APA Style
Xu, T., Tuerxun, P., Liu, N., Ji, C., Zhao, K., Qian, Y., Abudushataer, A., Li, Y., Jiang, X., Xiong, Z., Wang, M., Jia, R., & Ge, Y.-Z.
(2025). Deferred Versus Upfront Cytoreductive Nephrectomy in MetaStatic Renal Cell Carcinoma: Comparative Survival Analysis in the Immunotherapy Era. Cancers, 17(19), 3136.
https://doi.org/10.3390/cancers17193136